Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Recurrent Uti: full-pipeline trial registry
2 of 3 indexed Recurrent Uti trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Recurrent Uti: 3 US clinical trials tracked, 2 recruiting.
Recurrent Uti is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Women and Infants Hospital of Rhode Island, running 1 of these trials.
Enrollment posture brief
Registry condition recurrent-uti
OPEN 2 | RECR 67% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Recurrent Uti lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Recurrent Uti on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Recurrent Uti is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
Ann & Robert H Lurie Children's Hospital of Chicago
NCT06149676
Intravesical Gentamicin to Prevent Recurrent UTI
Women and Infants Hospital of Rhode Island
NCT06332781
Probiotics and Multi-Drug Resistant Urinary Tract Infection
Ochsner Health System
NCT03644966
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Recurrent Uti records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Recurrent Uti trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Recurrent Uti page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Recurrent Uti trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Women and Infants Hospital of Rhode Island sponsors the most Recurrent Uti trials on record, review their full trial history before evaluating a specific study. See Women and Infants Hospital of Rhode Island's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrent Uti condition card totals 3 registered trials; most-linked intervention Bifidobacterium infantis; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.